Investing Profile

Markus Goebel

Advisor

Biotech & Medtech consulting

Switzerland
Photo of Markus Goebel, Advisor

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Advisor
4
CompanyStageDateRound SizeTotal Raised
Merganser Biotech
Series AFeb 2015$28M
$28M
Co-investors: James N. Topper (Frazier Healthcare Partners)
Sorbent Therapeutics
Series DMay 2014$6.5M
Venture RoundAug 2012$18M
Series BJun 2011$36M
$100M
Co-investors: Scott Minick (ARCH Venture Partners)
Managing Director Novartis Venture Fund2004 - 2019
Head Pharma Corporate M&A Novartis2002 - 2004
Head Nervous System BD&L Pharma Novartis2000 - 2002
University of Hamburg PhD ADPRibosylation
Henley Management College MBA
Ludwig-Maximilians Universität München MD